Activation of Protein Serine/Threonine Phosphatase PP2C alpha Efficiently Prevents Liver Fibrosis | |
Wang, Lirui1; Wang, Xu1; Chen, Jing1; Yang, Zhengyi1; Yu, Liang1; Hu, Lihong1; Shen, Xu1,2 | |
刊名 | PLOS ONE |
2010-12-06 | |
卷号 | 5期号:12 |
ISSN号 | 1932-6203 |
DOI | 10.1371/journal.pone.0014230 |
文献子类 | Article |
英文摘要 | Background: Over-activation of TGF beta signaling pathway and uncontrolled cell proliferation of hepatic stellate cells (HSCs) play pivotal roles in liver fibrogenesis, while the protein serine/threonine phosphatase PP2C alpha was reported to negatively regulate TGF beta signaling pathway and cell cycle. Our study aimed to investigate the role of PP2C alpha in liver fibrogenesis. Methodology/Principal Findings: The effects of PP2C alpha activation on liver fibrosis were investigated in human HSCs and primary rat HSCs in vitro using western blotting, real-time PCR, nuclear translocation, cell viability and cell cycle analyses. The antifibrogenic effects in carbon tetrachloride (CCl4)-and bile duct ligation (BDL)-induced mice in vivo were assessed using biochemical, histological and immunohistochemical analyses. The results demonstrated that activation of PP2C alpha by overexpression or the new discovered small molecular activator NPLC0393 terminated TGF beta-Smad3 and TGF beta-p38 signaling pathways, induced cell cycle arrest in HSCs and decreased alpha-smooth muscle actin (alpha-SMA) expression, collagen deposition and hepatic hydroxyproline (HYP) level in CCl4- and BDL-induced mice. Conclusions/Significance: Our findings suggested that PP2C alpha activation might be an attractive new strategy for treating liver fibrosis while the small molecular activator NPLC0393 might represent a lead compound for antifibrogenic drug development. Moreover, our study might provide the first evidence for the role of PP2C family members in the fibrotic disease. |
资助项目 | State Key Program of Basic Research of China[2010CB912501] ; State Key Program of Basic Research of China[2007CB914304] ; State Key Program of Basic Research of China[2009CB918502] ; National Natural Science Foundation of China[30925040] ; National Natural Science Foundation of China[30890044] ; National Natural Science Foundation of China[10979072] ; Key New Drug Creation and Manufacturing Program[2009ZX09301-001] ; Science Foundation of Shanghai[08431902900] ; E-Institutes of Shanghai Municipal Education Commission[E09013] ; Foundation of Chinese Academy of Sciences[KSCX2-YW-R-168] ; Foundation of Chinese Academy of Sciences[SCX1-YW-02-2] |
WOS关键词 | GROWTH-FACTOR-BETA ; HEPATIC STELLATE CELLS ; I RECEPTOR KINASE ; APOPTOSIS ; INHIBITOR ; 2C-ALPHA ; RATS ; 2C ; PROLIFERATION ; AMPLIFICATION |
WOS研究方向 | Science & Technology - Other Topics |
语种 | 英语 |
出版者 | PUBLIC LIBRARY SCIENCE |
WOS记录号 | WOS:000284995300002 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/278692] |
专题 | 药理学第三研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Wang, Lirui |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; 2.Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Municipal Educ Commiss, Shanghai 200030, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Lirui,Wang, Xu,Chen, Jing,et al. Activation of Protein Serine/Threonine Phosphatase PP2C alpha Efficiently Prevents Liver Fibrosis[J]. PLOS ONE,2010,5(12). |
APA | Wang, Lirui.,Wang, Xu.,Chen, Jing.,Yang, Zhengyi.,Yu, Liang.,...&Shen, Xu.(2010).Activation of Protein Serine/Threonine Phosphatase PP2C alpha Efficiently Prevents Liver Fibrosis.PLOS ONE,5(12). |
MLA | Wang, Lirui,et al."Activation of Protein Serine/Threonine Phosphatase PP2C alpha Efficiently Prevents Liver Fibrosis".PLOS ONE 5.12(2010). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论